Emend Intravenous and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Emend Intravenous and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: Fosaprepitant
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend Intravenous-Lithium ER
- Emend Intravenous-Lithium Oral Solution
- Emend Intravenous-Lithium Salts
- Emend Intravenous-Lithium Syrup and Oral Solution
- Emend Intravenous-Lithobid
- Emend Intravenous-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Emflaza
- Lithium Controlled-Release and Extended-Release Tablets-Emflaza (Deflazacort Oral Suspension)
- Lithium Controlled-Release and Extended-Release Tablets-Emflaza (Deflazacort Tablets)
- Lithium Controlled-Release and Extended-Release Tablets-Emicizumab
- Lithium Controlled-Release and Extended-Release Tablets-Emicizumab-kxwh
- Lithium Controlled-Release and Extended-Release Tablets-Emicizumab-kxwh Subcutaneous